Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Crossref

1. CHARACTERISTICS OF LEVELS OF SERUM MARKERS OF APOPTOSIS FAS-SYSTEMS IN HIV-MONO-INFECTED PERSONS, PATIENTS WITH HIV/HCV-CO-INFECTION AND CHRONIC VIRAL HEPATITIS C

- E. A. Bazykina

- V. B. Turkutyukov

- O. E. Trotsenko

- V. O. Kotova

- L. A. Balakhontseva

2. Synergistic interaction of the cannabinoid and death receptor systems – a potential target for future cancer therapies?

- Attila Keresztes

- John M. Streicher

3. Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation

- Zhen-Tang Jing

- Wei Liu

- Shu-Xiang Wu

- Yun He

- Yan-Ting Lin

- Wan-Nan Chen

- Xin-Jian Lin

- Xu Lin

4. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis

- Ben-sheng Dong

- Fu-qun Liu

- Wen-na Yang

- Xiao-dong Li

- Miao-juan Shi

- Mao-rong Li

- Xiu-li Yan

- Hui Zhang

5. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients

- Mohamed El-Mesery

- Mohammed El-Mowafy

- Abdelaziz Elgaml

- Laila F. Youssef

- Sally Y. Abed

6. Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection

- Claudio Mastroianni

- Miriam Lichtner

- Claudia Mascia

- Paola Zuccalà

- Vincenzo Vullo

7. Expression of cluster of differentiation-95 and relevant signaling molecules in liver cancer

- XUMING WANG

- KANGLAI WEI

- QIONGGUANG ZHANG

- SIEN ZENG

- JING LIN

- LI QIAO

- LIJIANG LIU

8. Role of Apoptosis in HIV Pathogenesis

- Cyril Jabea Ekabe

- Njinju Asaba Clinton

- Eugene Kusi Agyei

- Jules Kehbila

- Majid Jabir

9. Exploring multiple quantitative trait loci models of hepatic fibrosis in a mouse intercross

- Rabea A. Hall

- Sonja Hillebrandt

- Frank Lammert

10.

11.

12. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection

- S. Tsiomita

- U. Georgopoulou

- P.P. Doumba

- J. Koskinas

- K. Adamidis

- C. Papaloukas

- G. Thyphronitis

13. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score

- El-Shatat A. Toson

- Gamal E. Shiha

- Hatem A. El-Mezayen

- Aml M. El-Sharkawy

14. IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans

- Fawaz Alzaid

- Floriane Lagadec

- Miguel Albuquerque

- Raphaëlle Ballaire

- Lucie Orliaguet

- Isabelle Hainault

- Corinne Blugeon

- Sophie Lemoine

- Agnès Lehuen

- David G. Saliba

- Irina A. Udalova

- Valérie Paradis

- Fabienne Foufelle

- Nicolas Venteclef

15. Intestinal IL-17R Signaling Constrains IL-18-Driven Liver Inflammation by the Regulation of Microbiome-Derived Products

- Patricia Castillo-dela Cruz

- Alanna G. Wanek

- Pawan Kumar

- Xiaojing An

- Waleed Elsegeiny

- William Horne

- Adam Fitch

- Ansen H.P. Burr

- Kathyayini P. Gopalakrishna

- Kong Chen

- Barbara A. Methé

- Scott W. Canna

- Timothy W. Hand

- Jay K. Kolls

16. Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells

- Qiuyue Zhang

- Jinchen Liu

- Haifeng Lin

- Bo Lin

- Mingyue Zhu

- Mengsen Li

17. Balance of apoptotic and anti-apoptotic marker and perforin granule release in squamous intraepithelial lesions. HIV infection leads to a decrease in perforin degranulation

- Ana Teresa G. Fernandes

- Natalia Pereira da Rocha

- Elyzabeth Avvad

- Beatriz J. Grinsztejn

- Fabio Russomano

- Aparecida Tristão

- Marcel de Souza Borges Quintana

- Mauricio A. Perez

- Fátima Conceição-Silva

- Maria da Gloria Bonecini-Almeida

18. Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease

- Francisco Javier Cubero

- Marius Maximilian Woitok

- Miguel E. Zoubek

- Alain de Bruin

- Maximilian Hatting

- Christian Trautwein

19. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy

- Li-Li Han